Akers Biosciences appoints chief executive after settling legal battle
8th Oct 2018 13:10
(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.
Read moreAkers Biosciences profits hit over antigen difficulties
15th Aug 2018 08:04
(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.
Read moreAkers Biosciences gains US patent for disposable cartridge
16th Feb 2017 08:44
(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea
Read moreAkers Biosciences to raise $2m in US placing
10th Jan 2017 12:06
(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa
Read moreAkers Biosciences signs three year deal with US hospital group
19th Dec 2016 14:52
(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov
Read moreAkers Biosciences gains European patent for ketone breath device
10th Nov 2016 09:46
(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows
Read moreAkers Biosciences, ChubeWorkx settle lengthy legal dispute
19th Aug 2016 12:18
(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli
Read moreDr Akers steps down as Akers Bioscience chairman
25th Apr 2016 14:07
(ShareCast News) - Rapid health information technology developer Akers Biosciences saw its founder and namesake Dr Raymond Akers step down as executive chairman on Monday, instead focusing on the firm's products and research. The AIM-traded company's current non-executive co-chairman, Thomas Knox, w
Read moreAkers Bioscience wins first China order for heparin test
2nd Mar 2016 13:57
(ShareCast News) - Akers Biosciences has won its first order from Chinese distributor NovoTek Therapeutics, worth $2.5m. The order is for Akers' handheld PIFA heparin allergy tests, which in November gained approval from the China Food and Drug Administration and will be exclusively sold and markete
Read moreAkers Biosciences launches ketosis fat-burning breath test via Amazon
14th Sep 2015 15:30
(ShareCast News) - Akers Biosciences has begun to make direct sales of its disposable breath ketone test, Metron, through the Amazon website and via the company's online sales portal. The medical device company said the Metron Breath Ketone Test, which is part of its health and wellness line, is the
Read moreAkers Biosciences plummets as interim loss widens
18th Aug 2015 11:28
(ShareCast News) - Akers Biosciences plummeted after the medical device company said its pre-tax loss widened in the first half as revenue declined. Akers posted a pre-tax loss of $3.41m for the six months ended 30 June, wider than the $1.1m loss in the same period last year. This included a one-tim
Read moreAkers Biosciences secures US distribution for heparin test
25th Jun 2014 12:10
Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin. The company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries, which it said was
Read moreAkers Biosciences signs distribution deal with US sales firm
4th Jun 2014 08:09
Akers Biosciences, which manufactures rapid diagnostic screening and testing products, has entered into a sales and distribution agreement with US-based Typenex Medical, a product development and sales organisation. Under the contract, which can be renewed after one year by mutual consent, the gro
Read moreAkers Biosciences to launch new product in India
16th May 2014 08:05
AIM-listed healthcare equipment firm Akers Biosciences has entered into an agreement with medical devices market developer Jai Capital to launch the group's PIFA Heparin/Platele in India. The Nevada-based group will market the company's product to the Indian military, which is allowed to buy produc
Read moreAkers Biosciences arranges Australia and UAE distribution deal
7th May 2014 10:54
AIM- and Nasdaq-listed healthcare equipment firm Akers Biosciences has signed a three-year distribution agreement to sell its products in Australia, Singapore, the United Arab Emirates and Oman. Dubai-based procurement company, 36S, will immediately begin marketing Aker's PIFA PLUSS infectious dis
Read more